US BANCORP \DE\ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 53 filers reported holding ONCOCYTE CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$115
-35.0%
5000.0%0.00%
Q1 2023$177
+9.9%
5000.0%0.00%
Q4 2022$1615000.0%0.00%
Q3 2022$05000.0%0.00%
Q2 2022$0
-100.0%
5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,000
-50.0%
5000.0%0.00%
Q3 2021$2,000
-33.3%
5000.0%0.00%
Q2 2021$3,0000.0%5000.0%0.00%
Q1 2021$3,000
+200.0%
5000.0%0.00%
Q4 2020$1,000
-80.0%
500
-86.7%
0.00%
Q3 2020$5,0003,7590.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders